Next Article in Journal
New Cation Sensors Based on Eugenol-Derived Azo Dyes
Next Article in Special Issue
Cascade Reactions of Indigo with an Allenylic Reactant
Previous Article in Journal
Development of an HPTLC-MS Method for the Differentiation of Celosiae Semen: Celosia argentea Versus C. cristata
Previous Article in Special Issue
General Synthesis of 2-Substituted Benzoxazoles Based on Tf2O-Promoted Electrophilic Activation of Tertiary Amides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments

1
Division of Science, Institute for Radiation Sciences, The University of Osaka, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan
2
State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, University of Chinese Academy of Sciences, 1 North 2nd Street, Zhongguancun, Haidian District, Beijing 100190, China
3
Department of Chemistry, Graduate School of Science, The University of Osaka, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan
4
Department of Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Kanagawa, Japan
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(13), 2787; https://doi.org/10.3390/molecules30132787
Submission received: 5 June 2025 / Revised: 22 June 2025 / Accepted: 26 June 2025 / Published: 28 June 2025
(This article belongs to the Special Issue 30th Anniversary of Molecules—Recent Advances in Organic Chemistry)

Abstract

Peptidoglycan (PGN) is a component of bacterial cell walls; its fragments are recognized by the cytoplasmic receptors Nod1 and Nod2, thereby promoting the production of inflammatory cytokines and antibodies. To further elucidate these biological defense mechanisms, a large and stable supply of the PGN fragments via chemical synthesis is essential. However, the synthesis and purification of long PGN fragments are quite challenging due to their low solubility. In this study, we efficiently synthesized PGN fragments via solid-phase oligosaccharide synthesis (SPOS). Using the JandaJel™ Wang resin (JJ-Wang), an octasaccharide glycan chain of PGN was constructed by repeating glycosylation reactions to elongate β-1,4-linked disaccharide units composed of MurNAc and GlcNAc. To enhance reactivity, glycosylation was performed in a mixed solvent comprising C4F9OEt/CH2Cl2/THF with the intention of promoting substrate concentration onto the solid support through the fluorophobic effect, affording the PGN octasaccharide in a 19% overall yield (10 steps). Subsequently, after deprotection of the O-Fmoc, N-Troc, and ethyl ester groups, N- and O-acetylation proceeded smoothly, owing to the high swelling property of JJ-Wang. Peptide condensation with L-Ala-D-isoGln(OBn) and carboxylic acids was also achieved. Finally, cleavage of the PGN fragment from the resin with TFA afforded the desired octasaccharide with dipeptides in a 2.3% overall yield (15 steps).

Graphical Abstract

1. Introduction

Solid-phase synthesis is a method for constructing molecules on inorganic or organic insoluble supports such as silica gel, alumina, and organic polymers. This technique is widely employed in peptide synthesis because it enables the stepwise construction of molecular backbones using sequential reactions with building blocks on a solid support, offering rapid synthesis without purification. In particular, the use of solid-phase peptide synthesizers enables efficient synthesis of long-chain peptides consisting of several tens of residues.
Solid-phase oligosaccharide synthesis (SPOS) is gaining increasing attention, particularly for the synthesis of glycans with repeating structures. Nicolaou et al. synthesized an elicitor-type dodecasaccharide using an o-nitrobenzyloxy benzoyl linker on a polystyrene resin, achieving a 10% yield over 10 steps [1,2]. Seeberger et al. made a major breakthrough in SPOS by developing the “Automated Solid-Phase Synthesis” system [3], enabling the efficient synthesis of long-chain glycans. Notably, they achieved the automated solid-phase synthesis of α-1,6-polymannosides comprising up to 100 monosaccharide units and also succeeded in constructing branched glycans containing 151 sugar units [4]. The contribution of Seeberger to the development of SPOS is of high significance, with his recent reports being outstanding, including SPOS of C1-functionalized and algal fucoidan oligosaccharides [5,6,7]. Furthermore, his development of automated synthesis equipment with integrated microwave irradiation has substantially reduced SPOS reaction times [8].
Boons et al. achieved α-selective glycosylation on solid support using an (S)-(phenylthiomethyl)benzyl group at the C2 position [9], where the formation of a trans-decalin-like intermediate facilitated axial attack by nucleophilic reagents, affording the α-glycoside in 25% yield (13 steps).
Codee et al. reported automated SPOS of β-mannuronic acid alginates [10]. They achieved 1,2-cis-β-selective glycosylation with a mannuronic acid donor to produce oligosaccharides in excellent yields: tetrasaccharide (47%), octasaccharide (20%), and dodecasaccharide (11%). Subsequent hydrogenation yielded β-mannuronic acid alginates, major components of algal cell walls. Furthermore, they reported an automated SPOS of oligorhamnans, which form a backbone of the bacteria cell wall of group A Streptococcus [11]. For α-selective glycosylation with dirhamnoside on the solid support, they employed cyanopivaloyl (PivCN) ester as a neighboring group, successfully synthesizing hexadecarhamnoside.
Demchenko et al. achieved SOPS of N-linked glycoprotein core glycans with β-selective mannosylation via hydrogen-bond-mediated aglycone delivery (HAD) of the picoloyl group [12]. They also developed an automated SPOS using a high-performance liquid chromatography (HPLC) system [13,14]. HPLC autosamplers can enable highly efficient investigation of key reactions, including glycosylation on the solid support. By using this system, SPOS of several oligosaccharides with [1→4] and [1→6] linkages was achieved.
Furthermore, our group reported SPOS of complex N-glycans [15]; using the JandaJel™ resin, the octasaccharide of N-glycan was successfully constructed in a 27% yield (11 steps). Such results highlight the utility of SPOS for the divergent and efficient synthesis of long-chain oligosaccharides. However, there are few reports on SPOS of glycoconjugates, such as glycopeptides and glycolipids, which is still under development [16,17].
Peptidoglycan (PGN), which is a major component of bacterial cell walls, has a repeating β-1,4-linkage structure of MurNAc and GlcNAc coupled with long peptide chains at the lactamide moiety of muramic acid to form three-dimensional bridge structures (Figure 1). Biologically, the PGN fragments promote the production of inflammatory cytokines and antibodies by binding to proteins, including the innate immune receptors Nod1 and Nod2, peptidoglycan recognition proteins (PGRPs), and other PGN-recognizing enzymes and lectins [18,19,20,21,22,23,24,25,26]. To further elucidate their biological functions, a stable supply of single and highly pure PGN fragments is essential.
We previously developed a method for the synthesis and evaluation of various types of PGN fragments [27,28,29,30,31,32,33,34,35,36,37]. PGN fragments of various lengths, including octasaccharides, were synthesized by 2 + 2 and 4 + 4 glycosylation. Moreover, di-, tri-, tetra-, penta-, and hepta-peptides were condensed into their PGN fragments. However, the purification of longer PGN fragments is challenging due to their low solubility. Furthermore, their reduced reactivity and increased number of reactive sites often require additional reaction and purification steps. To overcome this challenge, we focused on SPOS. In 2014, we reported the first successful SPOS of a PGN tetrasaccharide with two dipeptide moieties [38], demonstrating both glycan elongation and peptide condensation onto multiple carboxylic acid cites of PGN fragments on a solid phase, thus expanding the scope of SPOS. In this study, we demonstrate the SPOS of PGN octasaccharide with four dipeptide moieties 1, based on detailed investigations of glycosylation, capping, and peptide coupling, with the aim of further extending the glycan chain and introducing additional dipeptide units. (Figure 2).

2. Results and Discussion

The synthetic strategy for the PGN fragments is shown in Scheme 1. The JandaJel™ Wang resin (JJ-Wang) was employed as a solid-phase support, exhibiting an ether-crosslinked polystyrene structure to ensure swelling [12,13,15,39,40,41,42]. A disaccharide composed of a muramyl and a glucosaminyl residue 2 was used as a glycosyl donor, with N-phenyl trifluoroacetimidate as a PGN repeating unit. The N-phenyl-trifluoroacetimidates developed by Yu enable glycosylation under relatively mild conditions [28,43] and are more suitable as donor substrates for less reactive acceptors on the resin than the trichloroacetimidate used in Schmidt glycosylation [36,44]. After the glycosylation reaction, the unreacted hydroxy groups were capped with acetyl groups. Subsequently, the Fmoc group was removed to expose a free hydroxy group as the next reactive site. By repeating glycosylation, acetyl capping, and Fmoc deprotection, octasaccharide 3 was obtained. The N-Troc groups were deprotected along with the ethyl esters and subsequently converted into N-Ac groups. The dipeptides were then condensed with the MurNAc moieties to obtain compound 4 on the resin. Finally, cleavage from the resin yielded the desired octasaccharide with dipeptides 1.
As reported in our previous study [38], glycosylation was conducted with donor 5 and TMSOTf at −15 °C on the JJ-Wang resin, affording the monosaccharide-loaded resin 6 in a moderate yield. In this study, the glycosylation conditions were further optimized; under optimal conditions, approximately 45% of the reactive sites of the resin were accessible (Table 1). Investigation of the optimal conditions involved using the JJ-Wang resin (50.0 mg: 1.0 mmol/g) with donor 5 (1.0 eq.) and TMSOTf (0.5 eq.) in CH2Cl2 at −15 °C for 1 h, affording 6 in a 22% yield (Entry 1). Increasing the amount of donor 5 to 2.0 and 3.0 eq. improved the yield to 35% and 45%, respectively (Entries 2 and 3). However, even with 3.0 eq. of 5, the loading of muramyl monosaccharide remained suboptimal. This low efficiency was attributed to the undesired cleavage of the p-oxybenzyl linker on JJ-Wang in the presence of TMSOTf (Scheme S5). To mitigate this, THF was introduced to reduce the Lewis acidity of TMSOTf, increasing the yield to 34% (Entry 4). Aiming to further improve the loading ratio, a mixture of CH2Cl2/THF (9:1) was employed, and glycosylation with donor 5 (1.0 eq.) at −15 °C for 1 h improved the yield to 44% (Entry 5). Extending the reaction time did not further enhance loading (Entry 6), and further yield improvement appeared limited due to steric hindrance near the p-oxybenzyl alcohol moiety (reactive functional group on the resin). Although the Wang ChemMatrix® resin (composed of flexible polyethylene glycol) offered better swelling and reduced steric hindrance, it afforded lower yields, possibly due to sequestration of TMSOTf by the ether groups on the resin (Scheme S2). Because the reactivity of free hydroxy groups on the polymer is heterogeneous, it is preferable not to introduce glycans at the less reactive hydroxy sites, as this can be advantageous for subsequent glycan chain elongation. Based on these findings, full glycosylation of all p-oxybenzyl groups was not pursued. Instead, the conditions of Entry 5 were selected as optimal for efficient synthesis.
After loading the muramyl monosaccharide, unreacted hydroxy groups of 6 were capped with acetyl groups to prevent the formation of immature PGN units (Scheme 2). However, the protection of the hydroxy groups under basic conditions such as Ac2O/Pyridine/CH2Cl2 (1:1:1) led to undesired deprotection of the Fmoc group and acetylation (Scheme S3). Ac capping under neutral conditions was, therefore, employed, using imidazole and DMAP·HCl as the nucleophilic catalysts under base-free conditions [45]. The cleavage of the muramyl monosaccharide from the resin was conducted in a mixture of TFA/CH2Cl2/THF/H2O as previously reported [38]. As expected, 8 was obtained in an 81% yield without formation of the acetylated byproduct 9.
The synthesis of the glycan chain of PGN containing muramyl and glucosaminyl disaccharides was examined under the optimized conditions (Scheme 3). First, the glycosylation was performed using donor 2 (1.0 eq.) and TMSOTf (0.5 eq.) in a CH2Cl2/THF mixed solvent at −15 °C for 1 h, resulting in 36% of the hydroxyl groups on JJ-Wang reacting with 2. Although the molecular weight of the donor was increased by more than 1.5 times, the loading efficiency onto the resin was maintained at a comparable level. After Ac capping of the free hydroxy groups with Ac2O (160.0 eq.), imidazole (20.0 eq.), and DMAP·HCl (5.0 eq.), disaccharide 11 was cleaved from the resin and obtained in an 84% yield without formation of the acetylated byproduct 12.
After obtaining disaccharide-loaded JJ-Wang resin 13 (41% loading), we investigated the elongation of the glycan chain (Scheme 4). Following acetyl capping and Fmoc deprotection of 13, acceptor 14 was glycosylated with donor 2 (2.4 equiv.) and TMSOTf (1.2 equiv.) to afford tetrasaccharide 15 (Table 2). However, the glycosylation yield was unsatisfactory at 56% (Entry 1).
The reactivity of functional groups on a polymer is often heterogeneous, depending on their local environment. In our system, we hypothesized that such variability, along with steric hindrance around the hydroxy groups, contributed to the reduced glycosylation efficiency. To address this issue, we introduced the fluorous solvent C4F9OEt. Due to its low polarity and the fluorophobic effect characteristic of fluorous solvents, C4F9OEt does not readily penetrate the ether-bridged structure of the JJ-Wang resin. Instead, the glycosyl donor is expected to accumulate within the resin matrix, swollen by CH2Cl2 and THF, owing to the fluorophobic effect, thereby facilitating its interaction with hydroxy groups. We previously demonstrated that highly efficient glycosylation using CH2Cl2/C4F9OEt enabled the synthesis of complex N-glycans [15], and we anticipated a similar enhancement effect in this system. Nonetheless, the 2 + 2 glycosylation yield remained modest at 61% [38].
We hypothesized that the glycosylation under harsh conditions (CH2Cl2/C4F9OEt/THF (9:10:1) for 3 h at 0 °C) led to the undesired cleavage of the p-oxybenzyl linker on JJ-Wang, prompting us to re-optimize the solvent composition, reaction time, and temperature. Using a modified solvent system of CH2Cl2/C4F9OEt/THF (5:4:1) at −15 °C for 1 h, to JJ-Wang, we achieved a significantly improved glycosylation yield of 83% (Entry 2). These optimized conditions are expected to facilitate further elongation of the glycan chain.
The synthesis of the PGN octasaccharide 20 was then examined (Scheme 5). Ac capping of 15 followed by Fmoc deprotection was conducted, and subsequent glycosylation with 2 under the optimized conditions (Table 2, Entry 2) yielded the hexasaccharide with a loading yield of 68%. The production of the hexasaccharide was confirmed via ESI-LIT-Orbitrap MS analysis after cleavage of 17 from the resin with TFA/CH2Cl2/THF/H2O (5:4:1:0.2). Similarly, the unreacted glycosyl acceptor on the resin underwent Ac capping. Glycosylation was performed under identical conditions using the glycosyl acceptor 18 obtained after Fmoc deprotection. However, a single glycosylation did not afford a satisfactory loading yield. Therefore, the reaction was repeated twice, resulting in the formation of the octasaccharide 19 with a loading yield of 76%. The synthesized solid-supported octasaccharide 19 was shaken with TFA/CH2Cl2/THF/H2O (5:4:1:0.2) at 40 °C for 2 h (2 cycles), and the reaction mixture was diluted and collected. After quenching and extraction, the MS peaks of the desired octasaccharide 20 were confirmed (Figure S1). Although partially constructed di-, tetra-, and hexa-saccharides were also observed, they were removed by silica gel and LH-20 column chromatography (Figure 3), affording pure 20 in 19% yield (10 steps, starting from 13, average yield > 84%).
The synthesis of the PGN octasaccharide with dipeptides 1 was then examined (Scheme 6). Fmoc deprotection of 19 was conducted using 30% Et3N in CH2Cl2, followed by hydrolysis of the muramic acid ethyl esters and N-Troc groups using LiOH in THF/dioxane/H2O (4:2:1) at 20 °C for 12 h (3 cycles) [46]. In the solution-phase synthesis of PGN, the deprotection steps involving N-Troc deprotection with Zn/Cu and ethyl ester hydrolysis with LiOH had to be conducted separately due to the difficulty in separating and re-deprotecting incomplete reaction products. In contrast, on the solid support, deprotection can be performed continuously without the need for purification. The liberated amino and hydroxyl groups were then acetylated with Ac2O/pyridine/CH2Cl2 (1:1:1) at 20 °C for 12 h (two cycles). Under these conditions, the free carboxylic acids may form mixed acetic anhydrides. Therefore, hydrolysis was performed using pyridine in THF/dioxane/H2O (4:2:1) at 20 °C for 24 h to yield the octasaccharide 21 with free carboxyl groups. Peptide condensation of 21 with dipeptides was performed using an excess amount of HCl·L-Ala-D-iso-Gln(OBn), HATU, and triethylamine in DMF at 0 to 20 °C for 24 h to obtain the PGN octasaccharide with dipeptides 4. Finally, cleavage of 4 was performed with TFA/CH2Cl2/THF/H2O (5:4:1:0.2) at 40 °C for 2 h (two cycles). After extraction of the cleaved reaction mixture with CHCl3/MeOH (20:1), short silica gel column chromatography and HPLC purification afforded the desired octasaccharide with dipeptide 1 in a 2.3% yield (15 steps, starting from 13, average yield > 77%). Moreover, the hydrogenation of 1 with Pd/C at 2 MPa was also successful, as confirmed by analysis via high resolution mass spectrometry (HRMS) of the deprotected product (Scheme S10).

3. Materials and Methods

3.1. Preparation of the Glycosyl Donors

The glycosyl donors 2 and 5 were synthesized from D-(+)-glucosamine hydrochloride (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) according to a previously reported method [37] and were stored in the fridge.

3.2. SPOS of PGN Fragments

SPOS was performed on tens of μmol or less scale. PGN fragments were synthesized on the solid support (see Supplementary Materials) via glycosylation at −15 °C for 1 h using the glycosyl donor, TMSOTf, and MS4A. Ac capping was performed under neutral conditions with Ac2O, imidazole, and DMAP·HCl in CH2Cl2. Fmoc deprotection was conducted with 30% Et3N in CH2Cl2. Hydrolysis of N-Troc and ethyl ester was performed with LiOH in THF/dioxane/H2O (4:2:1), while N- and O-acetylation was conducted with Ac2O/pyridine/CH2Cl2 (1:1:1). Peptide condensation was achieved using HCl·L-Ala-D-iso-Gln(OBn), HATU, and triethylamine in DMF. The cleavage of the PGN fragments from JJ-Wang was performed with TFA/CH2Cl2/THF/H2O (5:4:1:0.2). Glycosylation yield was calculated by the absorbance of 9-methylidenefluorene after deprotection of Fmoc group with 30% Et3N in CH2Cl2. The compounds cleaved from JJ-Wang were isolated and the yields were calculated.

3.3. Purification of the PGN Fragments

Compound 20 was purified via silica gel column chromatography (toluene/EtOAc) and LH-20 column chromatography (CHCl3/MeOH). Compound 1 was purified via silica gel column chromatography (CHCl3/MeOH), LH-20 column chromatography (CHCl3/MeOH) and HPLC (see Supplementary Materials). Other compounds were purified via silica gel column chromatography.

3.4. Analysis of the PGN Fragments

Compound 1 was analyzed via nuclear magnetic resonance (NMR), high-resolution mass spectrometer (HRMS) and thin-layer chromatography (TLC). Other PGN fragments were analyzed via nuclear magnetic resonance (NMR), high-resolution mass spectrometer (HRMS), infrared spectroscopy (IR), specific rotation, thin-layer chromatography (TLC), and melting point measurement (see Supplementary Materials).

4. Conclusions

In this study, we successfully synthesized octasaccharides bearing dipeptide 1 using solid-phase oligosaccharide synthesis (SPOS). The JandaJel™ resin, which has high swelling capacity, was employed to expect high reactivity of glycosylation [15]. The relatively stable N-phenyl-trifluoroacetimidate donors were suitable for glycosylation on the resin. The addition of THF suppressed the Lewis acidity of TMSOTf, thereby preventing retro-glycosylation of p-oxybenzyl groups on the resin. Notably, the amide and ether of the glycan chain reduced the glycosylation reactivity. However, the use of fluorous solvent C4F9OEt addressed this limitation. C4F9OEt concentrated the donor 2 on the resin, enabling efficient synthesis of PGN octasaccharide 20 in 19% yield (10 steps). Subsequent hydrolysis and acetylation proceeded smoothly to afford the carboxylic acid 21. Furthermore, multiple peptide condensations of 21 with dipeptides were achieved. Finally, the cleavage of 4 from the resin using TFA yielded the PGN octasaccharide with dipeptide 1 in 2.3% yield (15 steps). While glycopeptide and glycolipid syntheses often require complex purification due to their poor physicochemical properties, SPOS, which eliminates the need for purification during synthesis, holds strong potential as a powerful strategy for advancing such complex synthetic processes.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules30132787/s1, Scheme S1: Glycosylation of muramyl monosaccharide 5 onto JandaJel™ Wang resin; Scheme S2: Glycosylation of muramyl monosaccharide 8 onto Wang ChemMatrix® resin; Scheme S3: Undesired deprotection and acetylation reaction during Ac capping; Scheme S4: Glycosylation of disaccharide 2 onto JJ-Wang and its cleavage from the resin; Scheme S5: Undesired cleavage of 10 with a Lewis acid; Scheme S6: Synthesis of octasaccharide 20; Scheme S7: SPOS of the solid-supported tetrasaccharide 15; Scheme S8: SPOS of octasaccharide 20; Scheme S9: SPOS of octasaccharide with dipeptides 1; Scheme S10: Synthesis of octasaccharide with dipeptides S8; Figure S1: MS-spectra of octasaccharide 20 (top: crude, bottom: pure); Table S1: HPLC conditions for the purification of 1; Content 8: 1H- and 13C NMR spectra.

Author Contributions

Conceptualization, Y.F. and K.F.; methodology, Y.K.; validation, Y.K.; formal analysis, Y.K.; investigation, Y.K.; data curation, Y.K.; writing—original draft preparation, Y.K.; writing—review and editing, Y.K., N.W., A.S. and Y.F. and K.F.; supervision, Y.F. and K.F.; project administration, Y.F. and K.F.; funding acquisition, Y.K., Y.F. and K.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded in part by the Grant-in-Aid for Specially Promoted Research (KAKENHI) 25H00006, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research, grant number JP23241074 and JP23K06049 from the Japan Society for the Promotion of Science; Grant-in-Aid for Scientific Research on Innovative Areas “Reaction Integration”, grand number 2105 from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Osaka University Global COE program (Frontier Biomedical Science Underlying Organelle Network Biology); ERATO Murata Lipid Active Structure Project; and Next Generation World-Leading Researchers (NEXT Program; LR025) from JSPS.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are shown in the manuscript and the Supplementary Materials.

Acknowledgments

We gratefully acknowledge Akihiro Ito at the Analytical Instrument Facility, Graduate School of Science, The University of Osaka, for supporting the HRMS measurements and Naoya Inazumi at the Analytical Instrument Facility, Graduate School of Science, The University of Osaka, for supporting the NMR measurements.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Nicolaou, K.C.; Watanabe, N.; Li, J.; Pastor, J.; Winssinger, N. Solid-phase synthesis of oligosaccharides: Construction of a dodecasaccharide. Angew. Chem. Int. Ed. Engl. 1998, 37, 1559–1561. [Google Scholar] [CrossRef]
  2. Nicolaou, K.C.; Winssinger, N.; Pastor, J.; DeRoose, F. A general and highly efficient solid phase synthesis of oligosaccharides. Total synthesis of a heptasaccharide phytoalexin elicitor (HPE). J. Am. Chem. Soc. 1997, 119, 449–450. [Google Scholar] [CrossRef]
  3. Plante, O.J.; Palmacci, E.R.; Seeberger, P.H. Automated solid-phase synthesis of oligosaccharides. Science 2001, 291, 1523–1527. [Google Scholar] [CrossRef]
  4. Joseph, A.A.; Pardo-Vargas, A.; Seeberger, P.H. Total Synthesis of Polysaccharides by Automated Glycan Assembly. J. Am. Chem. Soc. 2020, 142, 8561–8564. [Google Scholar] [CrossRef]
  5. Niggemeyer, G.B.; Danglad-Flores, J.A.; Seeberger, P.H. Automated synthesis of C1-functionalized oligosaccharides. J. Am. Chem. Soc. 2025, 147, 1649–1655. [Google Scholar] [CrossRef] [PubMed]
  6. Crawford, C.J.; Schultz-Johansen, M.; Luong, P.; Vidal-Melgosa, S.; Hehemann, J.-H.; Seeberger, P.H. Automated synthesis of algal fucoidan oligosaccharides. J. Am. Chem. Soc. 2024, 146, 18320–18330. [Google Scholar] [CrossRef]
  7. Zhu, Y.; Delbianco, M.; Seeberger, P.H. Automated assembly of starch and glycogen polysaccharides. J. Am. Chem. Soc. 2021, 143, 9758–9768. [Google Scholar] [CrossRef]
  8. Danglad-Flores, J.; Leichnitz, S.; Sletten, E.T.; Abragam Joseph, A.; Bienert, K.; Le Mai Hoang, K.; Seeberger, P.H. Microwave-assisted automated glycan assembly. J. Am. Chem. Soc. 2021, 143, 8893–8901. [Google Scholar] [CrossRef] [PubMed]
  9. Boltje, T.J.; Kim, J.-H.; Park, J.; Boons, G.-J. Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched α-glucan. Nat. Chem. 2010, 2, 552–557. [Google Scholar] [CrossRef]
  10. Walvoort, M.T.C.; van den Elst, H.; Plante, O.J.; Krcck, L.; Seeberger, P.H.; Overkleeft, H.S.; van der Marel, G.A.; Codee, J.D.C. Automated solid-phase synthesis of β-mannuronic acid alginates. Angew. Chem. Int. Ed. 2012, 51, 4393–4396. [Google Scholar] [CrossRef]
  11. Geert Volbeda, A.G.; van Mechelen, J.; Meeuwenoord, N.; Overkleeft, H.S.; van der Marel, G.A.; Codée, J.D.C. Cyanopivaloyl ester in the automated solid-phase synthesis of oligorhamnans. J. Org. Chem. 2017, 82, 12992–13002. [Google Scholar] [CrossRef] [PubMed]
  12. Pistorio, S.G.; Geringer, S.A.; Stine, K.J.; Demchenko, A.V. Manual and automated syntheses of the N-linked glycoprotein Core Glycans. J. Org. Chem. 2019, 84, 6576–6588. [Google Scholar] [CrossRef] [PubMed]
  13. Panza, M.; Stine, K.J.; Demchenko, A.V. HPLC-assisted automated oligosaccharide synthesis: The implementation of the two-way split valve as a mode of complete automation. Chem. Commun. 2020, 56, 1333–1336. [Google Scholar] [CrossRef] [PubMed]
  14. Ganesh, N.V.; Fujikawa, K.; Tan, Y.H.; Stine, K.J.; Demchenko, A.V. HPLC-assisted automated oligosaccharide synthesis. Org. Lett. 2012, 14, 3036–3039. [Google Scholar] [CrossRef] [PubMed]
  15. Tanaka, K.; Fujii, Y.; Tokimoto, H.; Mori, Y.; Tanaka, S.; Bao, G.M.; Siwu, E.R.O.; Nakayabu, A.; Fukase, K. Synthesis of a sialic acid containing complex-type N-glycan on a solid support. Chem. Asian J. 2009, 4, 574–580. [Google Scholar] [CrossRef]
  16. Ricardo, M.G.; Seeberger, P.H. Merging solid-phase peptide synthesis and automated glycan assembly to prepare lipid-peptide-glycan chimeras. Chemistry 2023, 29, e202301678. [Google Scholar] [CrossRef]
  17. Hurevich, M.; Seeberger, P.H. Automated glycopeptide assembly by combined solid-phase peptide and oligosaccharide synthesis. Chem. Commun. 2014, 50, 1851–1853. [Google Scholar] [CrossRef]
  18. Mesnage, S.; Dellarole, M.; Baxter, N.J.; Rouget, J.-B.; Dimitrov, J.D.; Wang, N.; Fujimoto, Y.; Hounslow, A.M.; Lacroix-Desmazes, S.; Fukase, K.; et al. Molecular basis for bacterial peptidoglycan recognition by LysM domains. Nat. Commun. 2014, 5, 4269. [Google Scholar] [CrossRef]
  19. Inohara, N.; Ogura, Y.; Fontalba, A.; Gutierrez, O.; Pons, F.; Crespo, J.; Fukase, K.; Inamura, S.; Kusumoto, S.; Hashimoto, M.; et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2. J. Biol. Chem. 2003, 278, 5509–5512. [Google Scholar] [CrossRef]
  20. Wang, Z.-M.; Li, X.; Cocklin, R.R.; Wang, M.; Wang, M.; Fukase, K.; Inamura, S.; Kusumoto, S.; Gupta, D.; Dziarski, R. Human peptidoglycan recognition protein-L Is an N-acetylmuramoyl-L-alanine amidase. J. Biol. Chem. 2003, 278, 49044–49052. [Google Scholar] [CrossRef]
  21. Resko, A.J.; Anderson, C.M.; Federle, M.J.; Alonzo, F., III. A staphylococcal glucosaminidase drives inflammatory responses by processing peptidoglycan chains to physiological lengths. Infect. Immun. 2023, 91, e00500-22. [Google Scholar] [CrossRef] [PubMed]
  22. Chamaillard, M.; Hashimoto, M.; Horie, Y.; Masumoto, J.; Qiu, S.; Saab, L.; Ogura, Y.; Kawasaki, A.; Fukase, K.; Kusumoto, S.; et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003, 4, 702–707. [Google Scholar] [CrossRef]
  23. Liang, Y.; Yang, L.; Wang, Y.; Tang, T.; Liu, F.; Zhang, F. Peptidoglycan recognition protein SC (PGRP-SC) shapes gut microbiota richness, diversity and composition by modulating immunity in the house fly Musca domestica. Insect Mol. Biol. 2023, 32, 200–212. [Google Scholar] [CrossRef] [PubMed]
  24. Bersch, K.L.; DeMeester, K.E.; Zagani, R.; Chen, S.; Wodzanowski, K.A.; Liu, S.; Mashayekh, S.; Reinecker, H.-C.; Grimes, C.L. Bacterial peptidoglycan fragments differentially regulate innate immune signaling. ACS Cent. Sci. 2021, 7, 688–696. [Google Scholar] [CrossRef]
  25. Wolf, A.J.; Underhill, D.M. Peptidoglycan recognition by the innate immune system. Nat. Rev. Immunol. 2018, 18, 243–254. [Google Scholar] [CrossRef] [PubMed]
  26. Yoshimura, A.; Lien, E.; Ingalls, R.R.; Tuomanen, E.; Dziarski, R.; Golenbock, D. Cutting Edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J. Immunol. 1999, 163, 1–5. [Google Scholar] [CrossRef]
  27. Wang, Q.; Marchetti, R.; Prisic, S.; Ishii, K.; Arai, Y.; Ohta, I.; Inuki, S.; Uchiyama, S.; Silipo, A.; Molinaro, A.; et al. A comprehensive study of the interaction between peptidoglycan fragments and the extracellular domain of Mycobacterium tuberculosis Ser/Thr kinase PknB. ChemBioChem 2017, 18, 2094–2098. [Google Scholar] [CrossRef]
  28. Wang, N.; Hasegawa, H.; Huang, C.-Y.; Fukase, K.; Fujimoto, Y. Synthesis of peptidoglycan fragments from Enterococcus faecalis with Fmoc-strategy for glycan elongation. Chem. Asian J. 2017, 12, 27–30. [Google Scholar] [CrossRef]
  29. Wang, N.; Hirata, A.; Nokihara, K.; Fukase, K.; Fujimoto, Y. Peptidoglycan microarray as a novel tool to explore protein–ligand recognition. Biopolymers 2016, 106, 422–429. [Google Scholar] [CrossRef]
  30. Wang, Q.; Matsuo, Y.; Pradipta, A.R.; Inohara, N.; Fujimoto, Y.; Fukase, K. Synthesis of characteristic Mycobacterium peptidoglycan (PGN) fragments utilizing with chemoenzymatic preparation of meso-diaminopimelic acid (DAP), and their modulation of innate immune responses. Org. Biomol. Chem. 2016, 14, 1013–1023. [Google Scholar] [CrossRef]
  31. Wang, N.; Huang, C.-Y.; Hasegawa, M.; Inohara, N.; Fujimoto, Y.; Fukase, K. Glycan sequence-dependent Nod2 activation investigated by using a chemically synthesized bacterial peptidoglycan fragment library. ChemBioChem 2013, 14, 482–488. [Google Scholar] [CrossRef] [PubMed]
  32. Fujimoto, Y.; Fukase, K. Structures, synthesis, and human Nod1 stimulation of immunostimulatory bacterial peptidoglycan fragments in the environment. J. Nat. Prod. 2011, 74, 518–525. [Google Scholar] [CrossRef]
  33. Fujimoto, Y.; Konishi, Y.; Kubo, O.; Hasegawa, M.; Inohara, N.; Fukase, K. Synthesis of crosslinked peptidoglycan fragments for investigation of their immunobiological functions. Tetrahedron Lett. 2009, 50, 3631–3634. [Google Scholar] [CrossRef]
  34. Kawasaki, A.; Inohara, N.; Fujimoto, Y.; Fukase, K. Synthesis of diaminopimelic acid containing peptidoglycan fragments and tracheal cytotoxin (TCT) and investigation of their biological functions. Chem. Eur. J. 2008, 14, 10318–10330. [Google Scholar] [CrossRef] [PubMed]
  35. Fujimoto, Y.; Inamura, S.; Kawasaki, A.; Shiokawa, Z.; Shimoyama, A.; Hashimoto, T.; Kusumoto, S.; Fukase, K. IEIIS Meeting minireview: Chemical synthesis of peptidoglycan fragments for elucidation of the immunostimulating mechanism. J. Endotoxin Res. 2007, 13, 189–196. [Google Scholar] [CrossRef] [PubMed]
  36. Inamura, S.; Fujimoto, Y.; Kawasaki, A.; Shiokawa, Z.; Woelk, E.; Heine, H.; Lindner, B.; Inohara, N.; Kusumoto, S.; Fukase, K. Synthesis of peptidoglycan fragments and evaluation of their biological activity. Org. Biomol. Chem. 2006, 4, 232–242. [Google Scholar] [CrossRef]
  37. Inamura, S.; Fukase, K.; Kusumoto, S. Synthetic study of peptidoglycan partial structures. Synthesis of tetrasaccharide and octasaccharide fragments. Tetrahedron Lett. 2001, 42, 7613–7616. [Google Scholar] [CrossRef]
  38. Kadonaga, Y.; Wang, N.; Fujimoto, Y.; Fukase, K. Solid-phase synthesis of bacterial cell wall peptidoglycan fragments. Chem. Lett. 2014, 43, 1461–1463. [Google Scholar] [CrossRef]
  39. Vaino, A.R.; Goodin, D.B.; Janda, K.D. Investigating resins for solid phase organic synthesis: The relationship between swelling and microenvironment as probed by EPR and fluorescence spectroscopy. J. Comb. Chem. 2000, 2, 330–336. [Google Scholar] [CrossRef]
  40. Gambs, C.; Dickerson, T.J.; Mahajan, S.; Pasternack, L.B.; Janda, K.D. High-resolution diffusion-ordered spectroscopy to probe the microenvironment of JandaJel and Merrifield resins. J. Org. Chem. 2003, 68, 3673–3678. [Google Scholar] [CrossRef]
  41. Collot, M.; Eller, S.; Weishaupt, M.; Seeberger, P.H. Glycosylation efficiencies on different solid supports using a hydrogenolysis-labile linker. Beilstein J. Org. Chem. 2013, 9, 97–105. [Google Scholar] [CrossRef] [PubMed]
  42. Lanari, D.; Ballini, R.; Bonollo, S.; Palmieri, A.; Pizzo, F.; Vaccaro, L. JandaJel as a polymeric support to improve the catalytic efficiency of immobilized-1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) under solvent-free conditions. Green Chem. 2011, 13, 3181–3186. [Google Scholar] [CrossRef]
  43. Yu, B.; Tao, H. Glycosyl trifuoroacetimidates. Part 1: Preparation and application as new glycosyl donors. Tetrahedron Lett. 2001, 42, 2405–2407. [Google Scholar] [CrossRef]
  44. Schmidt, R.R.; Michel, J. Facile synthesis of α- and β-O-glycosyl imidates; preparation of glycosides and disaccharides. Angew. Chem. Int. Ed. Engl. 1980, 19, 731–732. [Google Scholar] [CrossRef]
  45. Liu, Z.; Ma, Q.; Liu, Y.; Wang, Q. 4-(N,N-dimethylamino)pyridine hydrochloride as a recyclable catalyst for acylation of inert alcohols: Substrate scope and reaction mechanism. Org. Lett. 2014, 16, 236–239. [Google Scholar] [CrossRef]
  46. Huang, C.-y.; Wang, N.; Fujiki, K.; Otsuka, Y.; Akamatsu, M.; Fujimoto, Y.; Fukase, K. Widely applicable deprotection method of 2,2,2-trichloroethoxycarbonyl (troc) group using tetrabutylammonium fluoride. J. Carbohydr. Chem. 2010, 29, 289–298. [Google Scholar] [CrossRef]
Figure 1. Structure of the bacterial cell wall peptidoglycan. GlcNAc: N-Acetyl glucosamine, MurNAc: N-Acetylmuramic acid.
Figure 1. Structure of the bacterial cell wall peptidoglycan. GlcNAc: N-Acetyl glucosamine, MurNAc: N-Acetylmuramic acid.
Molecules 30 02787 g001
Figure 2. Structure of octasaccharide with four dipeptide moieties 1.
Figure 2. Structure of octasaccharide with four dipeptide moieties 1.
Molecules 30 02787 g002
Scheme 1. Synthetic strategy of octasaccharide with dipeptides 1.
Scheme 1. Synthetic strategy of octasaccharide with dipeptides 1.
Molecules 30 02787 sch001
Scheme 2. Ac capping and cleavage from resin.
Scheme 2. Ac capping and cleavage from resin.
Molecules 30 02787 sch002
Scheme 3. Introduction of disaccharide 2, Ac capping, and cleavage from resin.
Scheme 3. Introduction of disaccharide 2, Ac capping, and cleavage from resin.
Molecules 30 02787 sch003
Scheme 4. Synthesis of the solid-supported tetrasaccharide 15.
Scheme 4. Synthesis of the solid-supported tetrasaccharide 15.
Molecules 30 02787 sch004
Scheme 5. Synthesis of octasaccharide 20.
Scheme 5. Synthesis of octasaccharide 20.
Molecules 30 02787 sch005
Figure 3. MS spectra of octasaccharide 20.
Figure 3. MS spectra of octasaccharide 20.
Molecules 30 02787 g003
Scheme 6. Synthesis of octasaccharide with dipeptides 1.
Scheme 6. Synthesis of octasaccharide with dipeptides 1.
Molecules 30 02787 sch006
Table 1. Investigation of the introduction of monosaccharides onto the resin.
Table 1. Investigation of the introduction of monosaccharides onto the resin.
Molecules 30 02787 i001
EntryDonor 5 (e.q.)Solvent (5.0 w/v %)Time (h)Loading Ratio (%) *1
1 *21.0CH2Cl2122
22.0CH2Cl2135
33.0CH2Cl2145
4 *21.0THF134
5 *21.0CH2Cl2/THF (9:1)144
61.0CH2Cl2/THF (9:1)344
*1 Loading ratio was calculated by the absorbance of 9-methylidenefluorene after deprotection of Fmoc group with 30% Et3N in CH2Cl2. *2 Reference [38].
Table 2. Investigation of 2 + 2 glycosylation on the resin (1415).
Table 2. Investigation of 2 + 2 glycosylation on the resin (1415).
EntrySolventGlycosylation Yield (%)
1CH2Cl2/THF (9:1)56
2CH2Cl2/C4F9OEt/THF (5:4:1)83
Glycosylation yield was calculated by the absorbance of 9-methylidenefluorene after deprotection of Fmoc group with 30% Et3N in CH2Cl2.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kadonaga, Y.; Wang, N.; Shimoyama, A.; Fujimoto, Y.; Fukase, K. Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments. Molecules 2025, 30, 2787. https://doi.org/10.3390/molecules30132787

AMA Style

Kadonaga Y, Wang N, Shimoyama A, Fujimoto Y, Fukase K. Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments. Molecules. 2025; 30(13):2787. https://doi.org/10.3390/molecules30132787

Chicago/Turabian Style

Kadonaga, Yuichiro, Ning Wang, Atsushi Shimoyama, Yukari Fujimoto, and Koichi Fukase. 2025. "Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments" Molecules 30, no. 13: 2787. https://doi.org/10.3390/molecules30132787

APA Style

Kadonaga, Y., Wang, N., Shimoyama, A., Fujimoto, Y., & Fukase, K. (2025). Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments. Molecules, 30(13), 2787. https://doi.org/10.3390/molecules30132787

Article Metrics

Back to TopTop